Reference
Valdazo Martin C, et al. Switching oral antiandrogenic treatment in patients with castrate metastatic prostate cancer: An analysis. European Journal of Hospital Pharmacy - Science and Practice 27 (Suppl. 1): A96 abstr. 4CPS-104, Mar 2020. Available from: URL: http://doi.org/10.1136/ejhpharm-2020-eahpconf.205 [abstract]
Rights and permissions
About this article
Cite this article
Abiraterone/enzalutamide/prednisone. Reactions Weekly 1829, 15 (2020). https://doi.org/10.1007/s40278-020-85605-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85605-7